Abstract
Context: Currently, the keyword ‘BDNF’ retrieves 7388 publications in Pubmed, which point to many directions. Objective: This paper aims to uncover patterns that are hidden under this huge mass of studies and then to review the most prominent sub-topics in ‘BDNF and mental health’. Method: Several semi-automatic tools employed, in order to present: 1. A visual representation of BDNFs main molecular pathways; 2. A table with all the components of this pathway that are known to be associated with human diseases; 3. A conceptual map of the whole literature; 4. A histogram of the mental disorders that are known to be associated with BDNF, as well as a review of the literature on each one of these topics. Results: The conceptual map suggests that the field is divided in two major sections: BDNF molecular pathways, receptors, other neurotrophins and neurotransmitters; and BDNF-related disorders. Among the latter, the mental disorders that are mostly related to BDNF are: depression, schizophrenia, Parkinson disease, Alzheimer disease, and bipolar disorder.
Keywords: neurotransmitters, neurotrophins, neurotrophic factor, olfactory system, neurotrophic factor (BDNF), review, data mining, bioinformatics, genetic neuroscience, BDNF
Current Neuropharmacology
Title: Bioinformatics Approach to BDNF and BDNF-Related Disorders
Volume: 9 Issue: 2
Author(s): Alvaro Machado Dias
Affiliation:
Keywords: neurotransmitters, neurotrophins, neurotrophic factor, olfactory system, neurotrophic factor (BDNF), review, data mining, bioinformatics, genetic neuroscience, BDNF
Abstract: Context: Currently, the keyword ‘BDNF’ retrieves 7388 publications in Pubmed, which point to many directions. Objective: This paper aims to uncover patterns that are hidden under this huge mass of studies and then to review the most prominent sub-topics in ‘BDNF and mental health’. Method: Several semi-automatic tools employed, in order to present: 1. A visual representation of BDNFs main molecular pathways; 2. A table with all the components of this pathway that are known to be associated with human diseases; 3. A conceptual map of the whole literature; 4. A histogram of the mental disorders that are known to be associated with BDNF, as well as a review of the literature on each one of these topics. Results: The conceptual map suggests that the field is divided in two major sections: BDNF molecular pathways, receptors, other neurotrophins and neurotransmitters; and BDNF-related disorders. Among the latter, the mental disorders that are mostly related to BDNF are: depression, schizophrenia, Parkinson disease, Alzheimer disease, and bipolar disorder.
Export Options
About this article
Cite this article as:
Machado Dias Alvaro, Bioinformatics Approach to BDNF and BDNF-Related Disorders, Current Neuropharmacology 2011; 9 (2) . https://dx.doi.org/10.2174/157015911795596586
DOI https://dx.doi.org/10.2174/157015911795596586 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Immunotherapy with Tumor Vaccines for the Treatment of Malignant Gliomas
Current Drug Discovery Technologies Manipulation of Dendritic Cells for Tumor Immunity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Many Faces of Amyloid β in Alzheimers Disease
Current Molecular Medicine CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis
Current Cancer Drug Targets Ubiquitylation and Cancer Development
Current Cancer Drug Targets Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment
Current Drug Targets Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways
Current Neurovascular Research NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
Current Drug Targets - CNS & Neurological Disorders Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Mediterranean Diet and Dementia of the Alzheimer Type
Current Aging Science Multi-Classifier Based on Hard Instances- New Method for Prediction of Human Immunodeficiency Virus Drug Resistance
Current Topics in Medicinal Chemistry Drug Nanocarriers and Functional Nanoparticles: Applications in Cancer Therapy
Current Drug Delivery Current and Potential Treatments for Cervical Cancer
Current Cancer Drug Targets Platelet-Activating Factor (PAF) Antagonists Attenuate Inflammatory- Based Pain: Potential Cellular and Anatomical Sites of PAF Action
Central Nervous System Agents in Medicinal Chemistry Omega-3 Polyunsaturated Fatty Acids and Cancer
Anti-Cancer Agents in Medicinal Chemistry Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status
Mini-Reviews in Medicinal Chemistry Interactions Between Cholinergic and Fibroblast Growth Factor Receptors in Brain Trophism and Plasticity
Current Protein & Peptide Science